Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with RCSD1-ABL1-positive acute lymphoblastic leukemia

Documenti analoghi

• Imatinib-induced long-term remission in a relapsed RCSD1-ABL1-positive acute lymphoblastic leukemia
  di: Perwein, Thomas, et al.
  Pubblicazione: (2016)
• A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34)
  di: Mustjoki, Satu, et al.
  Pubblicazione: (2009)
• RCSD1-ABL1 Translocation Associated with IKZF1 Gene Deletion in B-Cell Acute Lymphoblastic Leukemia
  di: Kamran, Shawana, et al.
  Pubblicazione: (2015)
• Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia
  di: Fei, Fei, et al.
  Pubblicazione: (2010)
• The third-time chronic myeloid leukemia in lymphoblastic crisis with ABL1 kinase mutation induced by decitabine, dexamethason combined with nilotinib and dasatinib
  di: Wang, Suli, et al.
  Pubblicazione: (2016)